Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
US11248052B2 · kind B2 · utility
1Cited by
52References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2019 |
| Grant date | Feb 15, 2022 |
| Priority date | — |
| Expiry date | Apr 13, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01031
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods relating to or derived from antigen binding proteins capable of inducing β-Klotho, and or FGF21-like mediated signaling. In embodiments, the antigen binding proteins specifically bind to a complex comprising β-Klotho and at least one of (i) FGFR1c, (ii) FGFR2c and (iii) FGFR3c.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.